IYÚ D, GLENN JR, WHITE AE, JOHNSON A, HEPTINSTALL S and FOX SC, 2012. The Role Of Prostanoid Receptors In Mediating The Effects Of Pge3 On Human Platelet Function. Thrombosis And Haemostasis. 107(4), (In Press.)
WIJEYERATNE YD, JOSHI R and HEPTINSTALL S, 2012. Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromes Clinical Pharmacology (Expert review). 5(3), 257-269 IYÚ, DAVID, GLENN, JACKIE R, WHITE, ANN E, FOX, SUE C and HEPTINSTALL, STAN, 2011. Adenosine Derived From ADP Can Contribute to Inhibition of Platelet Aggregation in the Presence of a P2Y12 Antagonist. Arteriosclerosis, thrombosis, and vascular biology. 31(2), 416-422 IYÚ, DAVID, JÜTTNER, MADLEN, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW J, FOX, SUSAN C and HEPTINSTALL, STAN, 2011. PGE(1) and PGE(2) modify platelet function through different prostanoid receptors. Prostaglandins & other lipid mediators. 94(1-2), 9-16 IYÚ, D, GLENN, J R, WHITE, A E, FOX, S C, VAN GIEZEN, H, NYLANDER, S and HEPTINSTALL, S, 2011. Mode of action of P2Y12 antagonists as inhibitors of platelet function. Thrombosis and Haemostasis. 105(1), 96-106 WIJEYERATNE YD and HEPTINSTALL S, 2011. Anti-Platelet Therapy: ADP Receptor Antagonists. British Journal Of Clinical Pharmacology. 72(4), 647-57 IYÚ, DAVID, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW J, FOX, SUSAN C and HEPTINSTALL, STAN, 2010. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Platelets. 21(5), 329-342 HEPTINSTALL, S, SPAULDING, C, DANSER, J, HALVORSEN, S, JAMES, S, TUOMILEHTO, J, HOHNLOSER, S, LEFÈVRE, T, CARMELIET, P and GITTENBERGER-DE GROOT, A.C., 2010. Photofeature: European cardiovascular researchers on holiday and outside of work Circulation. 122(7), f40-f42
MAHAJAN, RAVI and HEPTINSTALL, STAN, 2010. Should critical care patients receive or remain on treatment with antiplatelet drugs? Critical Care Medicine. 38(1), 298-300
SAMAMA, MEYER M, KUNITADA, SATOSHI, OURSIN, ANDŖE, DEPASSE, FRANCOIS and HEPTINSTALL, STAN, 2010. Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: A randomised controlled trial in healthy elderly adults. Thrombosis Research. 126(4), e286-293 FOX, S C, MAY, J A, SHAH, A, NEUBERT, U and HEPTINSTALL, S, 2009. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets. 20(4), 250-9
DOVLATOVA, N., WIJEYERATNE, Y.D., FOX, S.C., MANOLOPOULOS, P., JOHNSON, A.J., WHITE, A.E., LATIF, L., RALEVIC, V. and HEPTINSTALL, S., 2009. Detection of P2Y14 receptor protein on platelets and investigation of the role of P2Y14 in platelet function. J Thromb Haemostas. Supplement 2, WE-045
HEPTINSTALL, S, FOX, S.C., MAY, J.A., HERMANN, D., STREITER, D. and HARTMAN, D., 2009. EP3 receptor blockade and platelet function in man. J Thromb Haemostas. MO-100
FOX, S.C., MAY, J.A., SHAH, A., NEUBERT, U. and HEPTINSTALL, S., 2009. Assessment of clopidogrel and aspirin therapy using remote platelet testing. J Thromb Haemostas. 7(Supplement 2), WE-755
IYU, D and HEPTINSTALL, S., 2009. Harnessing the antiplatelet effects of prostaglandin E2 by EP3 receptor blockade. J Thromb Haemost. 7(Supplement 2), MO-101
STOREY, ROBERT F, MELISSA THORNTON, S, LAWRANCE, RACHAEL, HUSTED, STEEN, WICKENS, MARK, EMANUELSSON, HÅKAN, CANNON, CHRISTOPHER P, HEPTINSTALL, STAN and ARMSTRONG, MARTIN, 2009. Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3. Platelets. 20(5), 341-8
VISIOLI, FRANCESCO, BERNAERT, HERWIG, CORTI, ROBERTO, FERRI, CLAUDIO, HEPTINSTALL, STAN, MOLINARI, ENRICO, POLI, ANDREA, SERAFINI, MAURO, SMIT, HENK J, VINSON, JOE A, VIOLI, FRANCESCO and PAOLETTI, RODOL, 2009. Chocolate, lifestyle, and health. Critical Reviews in Food Science and Nutrition. 49(4), 299-312
HEPTINSTALL, STAN, ESPINOSA, DAVID IYU, MANOLOPOULOS, PANAGIOTIS, GLENN, JACKIE R, WHITE, ANN E, JOHNSON, ANDREW, DOVLATOVA, NATALIA, FOX, SUE C, MAY, JANE A, HERMANN, DAVID, MAGNUSSON, OLAFUR and STEFAN, 2008. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8), 605-13
MAY, JANE A, FOX, SUE, GLENN, JACKIE, CRAXFORD, SIMON and HEPTINSTALL, STAN, 2008. Platelet function reduces significantly during the morning. Platelets. 19(7), 556-8
DOVLATOVA, NATALIA, WIJEYERATNE, YANUSHI D, FOX, SUSAN C, MANOLOPOULOS, PANAGIOTIS, JOHNSON, ANDREW J, WHITE, ANN E, LATIF, M LIAQUE, RALEVIC, VERA and HEPTINSTALL, STANLEY, 2008. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor. Thrombosis and Haemostasis. 100(2), 261-70 MANOLOPOULOS, P, GLENN, J R, FOX, S C, MAY, J A, DOVLATOVA, N L, TANG, S-W, THOMAS, N R, RALEVIC, V and HEPTINSTALL, S, 2008. Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents. Platelets. 19(2), 134-45
GLENN, J R, WHITE, A E, JOHNSON, A J, FOX, S C, MYERS, B and HEPTINSTALL, S, 2008. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Platelets. 19(1), 59-69
DOVLATOVA, N L, JAKUBOWSKI, J A, SUGIDACHI, A and HEPTINSTALL, S, 2008. The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function. Journal of Thrombosis and Haemostasis: JTH. 6(7), 1153-9
JOHNSON, A, DOVLATOVA, N and AND HEPTINSTALL, H., 2008. Multiple electrode aggregometry and P2Y12 antagonists Thrombosis and Haemostasis. 99(6), 1127-1129 JOHNSON, ANDREW, DOVLATOVA, NATALIA and HEPTINSTALL, STAN, 2008. Multiple electrode aggregometry and P2Y(12) antagonists. Thrombosis and Haemostasis. 99(6), 1127-9 HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and AND MYERS, B., 2007. Leucocytes influence platelet aggregation more than you think Platelets. 18(1), 77-78 WHITE, A., GLENN, J., FOX, S., JOHNSON, A., MYERS, B. and AND HEPTINSTALL, S., 2007. Reduced platelet aggregation to ADP and ATP in patients with leucocytosis is due to enhanced rates of adenine nucleotide metabolism mediated by the NTPDase CD39 Platelets. 18(1), 100 HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R and JOHNSON, A.J. AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Thrombosis Research. 120(Supplement 2), S153-S154
HEPTINSTALL, S, MYERS, B, FOX, S.C, GLENN, J.R, JOHNSON, A.J and AND WHITE, A.E., 2007. Raised levels of CD39 in leucocytosis result in marked inhibition of ADP-induced platelet aggregation via rapid ADP hydrolysis. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-356
XAVIER, R, WHITE, A, FOX, S, WILCOX, R and AND HEPTINSTALL, S., 2007. Enhanced platelet aggregation and activation under conditions of hypothermia Thrombosis and Haemostasis. 98(6), 1266-1275 FOX, S.C, MAY, J.A and AND HEPTINSTALL, S., 2007. Measurement of endothelial microparticles in blood is impaired if chylomicrons are present after a fatty meal. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-526
MAY, J.A, FOX, S.C, HEPTINSTALL, S and AND KWIK-URIBE, C., 2007. Effects of a flavanol-rich cocoa beverage on platelet and leucocyte function in man. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-T-685
XAVIER, R, WHITE, A, FOX, S and AND HEPTINSTALL, S., 2007. Platelet aggregation is enhanced under conditions of hypothermia. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-320
STOREY, R.F, HUSTED, S, HARRINGTON, R.A, HEPTINSTALL, S, WILCOX, R.G, PETERS, G, WICKENS, M, EMANUELSSON, H, GURBEL, P, GRANDE, P and AND CANNON, C.P., 2007. Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12 Receptor Antagonist, Compared with Clopidogrel in Patients with Acute Coronary Syndromes. Journal of the American College of Cardiology. 50(19), 1852-1856 (In Press.)
WIJEYERATNE, Y.D, WHITE, A.E, RALEVIC, V and AND HEPTINSTALL, S., 2007. Comparison of the effects of the P2Y14 receptor agonist UDP-glucose and the EP3 receptor agonist sulprostone on platelet function. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-280
WIRE, R, MAY, J.A, HEPTINSTALL, S, CHEN, D, LU,Y and AND ZHAO, L., 2007. Heteroclitin D, A component of plants of the Kadsura species inhibits paf-induced platelet aggregation, P-selectin expression and platelet-leucocyte conjugate formation. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-344
DOVLATOVA, N.L, JAKUBOWSKI, J.A, SUGIDACHI, A and AND HEPTINSTALL, S., 2007. Competition between reversible and irreversible P2Y12 antagonists and its influence on ADP-mediated platelet activation. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-340
STOREY, R., HARRINGTON, R, A., HUSTED, S., HEPTINSTALL, S., WILCOX, R., GURBEL, A., GRANDE, P., WICKENS, M., PETERS, G., EMANUELSSON, H. and CANNON, C., 2007. AZD6140 Suppresses Platelet Aggregation in Clopidogrel-Treated Patients Even in Those With High Aggregation Levels JACC. 49(9 (Supplement A)),
HEPTINSTALL, S, ANDERS, R, GURNEY, M, HERMANN, D and AND HARTMAN, D., 2007. EP3 receptors - a new target for inhibition of platelet aggregation and platelet-leucocyte conjugate formation. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-W-273
HEPTINSTALL, S, ANDERS, R, GURNEY, M, HERMANN, D and AND HARTMAN, D., 2007. EP3 Receptors: A new target for inhibition of platelet function in inflammatory thrombotic disease. Arteriosclerosis Thrombosis and Vascular Biology. 27(e109),
MANOLOPOULOS, P, IYU ESPINOSA, D, ANDERS, B, GURNEY, M, HERMANN, D, HARTMAN, D and AND HEPTINSTALL, S., 2007. Platelet EP3 receptors as targets for antithrombotic agents - comparison of DG-041 with aspirin and AR-C69931. Journal of Thrombosis and Haemostasis: JTH. 5(Supplement 2), P-S-345
HEPTINSTALL, S., FOX, S., GLENN, J., JOHNSON, A., WHITE, A., HATZINOCOLAU, M., PINK, A., STAFFORD, N., BEHAN, M., DOLAN, G. and MYERS, B., 2006. Effects of blood leucocytes on platelet aggregation - a review of recent studies on leucocytes, adenine nucleotide metabolism and CD39 Seminars in Cardiology. 12(2), 43-54 HEPTINSTALL, STAN, GLENN, JACQUELINE R, JOHNSON, ANDREW, MYERS, BETHAN, WHITE, ANN E and ZHAO, LIAN, 2006. Leukocytosis, vascular disease, and adenine nucleotide metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology. 26(2), e22-3 HEPTINSTALL, STAN, MAY, JANE, FOX, SUE, KWIK-URIBE, CATHERINE and ZHAO, LIAN, 2006. Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults. Journal of cardiovascular pharmacology. 47 Suppl 2, S197-205; discussion S206-9 ZHAO, LIAN, GRAY, LAURA, LEONARDI-BEE, JO, WEAVER, CHRIS S, HEPTINSTALL, STAN and BATH, PHILIP M W, 2006. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke. Platelets. 17(2), 100-4 HUSTED, S., EMANUELSSON, H., HEPTINSTALL, S., SANDSET, P.M., WICKENS, M. and PETERS, G., 2006. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y<sub>12</sub> antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin European Heart Journal. 27(9), 1038-1047 HEPTINSTALL, S., FOX, S.C., GLENN, J.R., JOHNSON, A., WHITE, A.E., DOLAN, G. and MYERS, B., 2006. Blood leucocytes are mobile modulators of adenine metabolism and play an important role in determining the effects of adenine nucleotides on platelet function. Purinergic Signalling. 2, 137
HEPTINSTALL, S., GLENN, J.R., JOHNSTON, A., WHITE, A. and MYERS, B., 2006. Leucocytes, leucocytosis and adenine nucleotide metabolism. Platelets. 17, 115
HEPTINSTALL, S., MANOLOPOULOS, M., GLENN, J.R., FOX, S.C., MAY, J.A., DOVLATOVA, N., TANG, S-W., BAUER, N., HESSE, M., THOMAS, N.R. and RALEVIC, V., 2006. Acyl derivatives of coenzyme A inhibit ADP-induced platelet function via antagonism at P2Y1 and P2Y12 receptors. Purinergic Signalling. 2, 92-93
STOREY R.F., HUSTED S, HARRINGTON R.A., HEPTINSTALL S., WILCOX R.G. and ET AL., 2006. AZD6140 Yields greater inhibition of platelet aggregation than clopidogrel in patients with acute coronary syndromes without previous clopidogrel treatment. In: 204 (A821)
HEPTINSTALL, S, 2006. Variable therapeutic effectiveness of clopidogrel in acute coronary syndromes. Journal of Thrombosis and Haemostasis: JTH. 4(3), 539-41 GLENN, JACQUELINE R, WHITE, ANN E, JOHNSON, ANDREW, FOX, SUSAN C, BEHAN, MILES W H, DOLAN, GERRY and HEPTINSTALL, STANLEY, 2005. Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood. Platelets. 16(3-4), 159-70 BEHAN, M.W.H., FOX, S.C., HEPTINSTALL, S. and STOREY, R.F., 2005. Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes Platelets. 16(2), 73-80 HEPTINSTALL, S., JOHNSON, A., GLENN, J.R. and WHITE, A.E., 2005. Adenine nucleotide metabolism in human blood - important roles for leukocytes and erythrocytes. Journal of Thrombosis and Haemostasis. 3(10), 2331-2339 HEPTINSTALL,S., TANG,S., MANOLOPOULOS,P., FOX,S., MAY,J., GLENN,J. and RALEVIC,V., 2005. Derivatives of coenzymes A inhibit platelet aggregation via efects at P2Y1 and P2Y12 receptors. In: 20th Congress of the International Society on Thrombosis & Haemostasis. OR334
ZHAO, L., SPRIGG, N., HEPTINSTALL, S. and BATH, P., 2005. Effects of granulocyte-colony stimulating factor on platelets and leukocyte function in whole blood in vitro. In: International Society of Thrombosis & Haemostasis. P02373
FOX, S.C., MANOLOPOULOS, P., MAY, J.A. and HEPTINSTALL, S., 2005. Platelet aggregation, microparticle formation and platelet-leukocyte conjugate formation induced by combinations of 5-HT and epinephrine are inhibited by Sarpogrelate and BP-984 In: International Society Thrombosis & Haemostasis, Sydney, Australia. PO2149
MAY, J., ZHAO, L. and HEPTINSTALL, S., 2005. Dietary flavanols - Effects on platelets and leukocytes. In: International Society of Thrombosis & Haemostasis. PO953
BATH, P.M.W., ZHAO, L. and HEPTINSTALL, S., 2005. Current status of stroke prevention in patients with atrial fibrillation European Heart Journal supplements. 7(Supplement C), C12-18 MANOLOPOULOS, P., FOX, S.C. and HEPTINSTALL, S., 2005. Involvement of P2Y1 and P2Y12 receptors in platelet responses to adenosine diphosphate and thrombin receptor activating peptide. In: International Society of Thrombosis & Haemostasis, Sydney 2005. PO1498
STOREY, ROBERT F, MAY, JANE A and HEPTINSTALL, STAN, 2005. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin. Thrombosis Research. 115(4), 301-7
HEPTINSTALL, S., 2005. The recent history of platelets in thrombosis and other disorders.. In: Wellcome Witnesses to the Twentieth Century Medicine 23.
FOX, S.C., SASAE, R., JANSON, S., MAY, J.A. and HEPTINSTALL, S., 2004. Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets. 15(2), 85-93 HEPTINSTALL S, TANG SW, MANOLOPOULOS P, FOX SC, MAY J, GLENN J, RALEVIC V., 2004. N0204-003 inhibits ADP-induced platelet function via antagonism at P2Y1 and In: Platelets. 493
FOX SC, SIEBERT D, MCMAHON A, MAY J, SPANGENBERG P, HEPTINSTALL S, 2004. Inhibitory effect of physical exercise on platelet aggregation in whole blood may be through In: Platelets. 490
FOX SC, MAY JA, MANOLOPOULOS P, HEPTINSTALL S, 2004. P2Y1 and P2Y12 purinergic receptor involvement in platelet responses induced by collagen and TRAP In: Platelets. 364
FOX SC, MAY JA, MANOLOPOULOS P, HEPTINSTALL S, 2004. P2Y1 and P2Y12 purinergic receptor involvement in platelet responses induced by collagen and TRAP In: Platelets. 364
MANOLOPOULOS P, FOX SC, HEPTINSTALL S., 2004. Involvement of P2Y1 and P2Y12 purinergic receptors in platelet responses to the combination of Adenosine Diphosphate and Thrombin Receptor Activating Peptide In: Platelets. 502
FOX SC, MANOLOPOULOS P, MAY J, HEPTINSTALL S, 2004. Studies on the effects of sarpogrelate and its active metabolite BP-984 on 5-HT-induced platelet activation In: Platelets. 490
ZHAO, LIAN, BATH, PHILIP, LöSCHE, WOLFGANG and HEPTINSTALL, STAN, 2004. Platelet-monocyte interaction and GPIIb/IIIa blockade. Thrombosis and Haemostasis. 92(4), 888-90
ZHAO, L., BATH, P.M., MAY, J., LOSCHE, W. and HEPTINSTALL, S., 2004. Correction. Platelets. 15, 63-63 HEPTINSTALL, STAN, GLENN, JACKIE R, MAY, JANE A, STOREY, ROBERT F and WILCOX, ROBERT G, 2004. Clopidogrel resistance. Catheterization and Cardiovascular Interventions. 63(3), 397-8 WILLMOT, MARK, ZHAO, LIAN, HEPTINSTALL, STAN and BATH, PHILIP, 2004. Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 13(3), 138-40
ZHAO, LIAN, BATH, PHILIP M W, MAY, JANE, LÃƑ¶SCHE, WOLFGANG and HEPTINSTALL, STAN, 2004. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist. Platelets. 14(7-8), 473-80
MAY, J. A. and HEPTINSTALL, S., 2004. Effects of Anticoagulants Used During Blood Collection on Human Platelet Function Methods in Molecular Biology. VOL 272, 3-12
MAY, JANE A and HEPTINSTALL, STANLEY, 2004. Effects of anticoagulants used during blood collection on human platelet function. Methods in Molecular Biology. 272, 3-11
ZHAO, L., BATH, P. M. W., FOX, S., MAY, J., JUDGE, H., LOSCHE, W. and HEPTINSTALL, S., 2003. The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions Current Medical Research and Opinion. VOL 19(PART 3), 178-186 STAFFORD, N.P., PINK, A.E., WHITE, A.E., GLENN, J.R. and HEPTINSTALL, S., 2003. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arteriosclerosis, Thrombosis, and Vascular Biology. 23(10), 1928-1933 EVANS, P.A., HEPTINSTALL, S., CROWHURST, E.C., DAVIES, T., GLENN, J.R., MADIRA, W., DAVIDSON, S.J., BURMAN, J.F., HOSKINSON, J. and STRAY, C.M., 2003. Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. Journal of Thrombosis and Haemostasis. 1(10), 2140-8 ZHAO, LIAN, BATH, PHILIP M W, FOX, SUE, MAY, JANE, JUDGE, HEATHER, LÖSCHE, WOLFGANG and HEPTINSTALL, STAN, 2003. The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current Medical Research and Opinion. 19(3), 178-86
EVANS, P A, CROWHURST, E C, GLENN, J A, DAVIES, T and HEPTINSTALL, S, 2003. Can the effects of clinical reperfusion fluids on platelet aggregation in vitro predict the effects of administration of such fluids in a clinical study ex vivo? Platelets. 14(4), 253-7 SCHOLZ, THOMAS, ZHAO, LIAN, TEMMLER, UTA, BATH, PHILIP, HEPTINSTALL, STAN and LöSCHE, WOLFGANG, 2002. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro. Platelets. 13(7), 401-6 STOREY, R. F., JUDGE, H. M., WILCOX, R. G. and HEPTINSTALL, S., 2002. Inhibition of ADP-induced P-selectin Expression and Platelet-Leukocyte Conjugate Formation by Clopidogrel and the P2Y~1~2 Receptor Antagonist AR-C69931MX but not Aspirin Thrombosis and Haemostasis. VOL 88(PART 3), 488-494
STOREY, ROBERT F, WILCOX, ROBERT G and HEPTINSTALL, STAN, 2002. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease. Platelets. 13(7), 407-13
SCHOLZ, THOMAS, TEMMLER, UTA, KRAUSE, SIEGFRIED, HEPTINSTALL, STAN and LöSCHE, WOLFGANG, 2002. Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thrombosis and Haemostasis. 88(6), 1033-8
DAVIES, A R, JUDGE, H M, MAY, J A, GLENN, J R and HEPTINSTALL, S, 2002. Interactions of platelets with Synthocytes, a novel platelet substitute. Platelets. 13(4), 197-205 STOREY, ROBERT F, JUDGE, HEATHER M, WILCOX, ROBERT G and HEPTINSTALL, STAN, 2002. Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin. Thrombosis and Haemostasis. 88(3), 488-94
STOREY, R F, SANDERSON, H M, WHITE, A E, MAY, J A, CAMERON, K E and HEPTINSTALL, S, 2000. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. British journal of haematology. 110(4), 925-34 STOREY, R. F., SANDERSON, H. M., WHITE, A. E., MAY, J. A., CAMERON, K. E. and HEPTINSTALL, S., 2000. The central role of the P~2~T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity British Journal of Haematology. VOL 110(PART 4), 925-934 NATARAJAN, P, MAY, J A, SANDERSON, H M, ZABE, M, SPANGENBERG, P and HEPTINSTALL, S, 2000. Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function. Platelets. 11(8), 467-76 STOREY, R F and HEPTINSTALL, S, 1999. Laboratory investigation of platelet function. Clinical and Laboratory Haematology. 21(5), 317-29 COLE, A T, HUDSON, N, LIEW, L C, MURRAY, F E, HAWKEY, C J and HEPTINSTALL, S, 1999. Protection of human gastric mucosa against aspirin-enteric coating or dose reduction? Alimentary Pharmacology and Therapeutics. 13(2), 187-93 TAYLOR, J E, PORTER, C, HEPTINSTALL, S, MCLAREN, M and BELCH, J J, 1999. Increased platelet activation in renal transplant patients. Platelets. 10(4), 223-7
STOREY, R F, MAY, J A, WILCOX, R G and HEPTINSTALL, S, 1999. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Thrombosis and haemostasis. 82(4), 1307-11
BROWN, N, MAY, J A, WILCOX, R G, ALLAN, L M, WILSON, A M, KIFF, P S and HEPTINSTALL, S, 1999. Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis. British Journal of Clinical Pharmacology. 48(1), 57-62 STOREY, R. F., MAY, J. A., WILCOX, R. G. and HEPTINSTALL, S., 1999. A Whole Blood Assay of Inhibition of Platelet Aggregation by Glycoprotein IIb/IIIa Antagonists: Comparison with other Aggregation Methodologies Thrombosis and Haemostasis. VOL 82(NUMBER 4), 1307-1311
PEIRCE, N S, FORSTER, C D, HEPTINSTALL, S and MACDONALD, I A, 1999. Unexpected changes in the catecholamine content of platelets and plasma during exercise. Platelets. 10(5), 312-8
HEPTINSTALL, S, WHITE, A, EDWARDS, N, PASCOE, J, SANDERSON, H M, FOX, S C and HENDERSON, R A, 1998. Differential effects of three radiographic contrast media on platelet aggregation and degranulation: implications for clinical practice? British Journal of Haematology. 103(4), 1023-30 LOWE,K.C., EDWARDS,C.M. and HEPTINSTALL,S., 1998. Anti-thrombotic effects of <i>Pluronic</i><sup>®</sup> F-68 in human whole blood <i>in vitro</i> Experimental Biology Online. 3(Supplement 1998 SEB Annual Meeting Abstracts of papers - York 22-27 March), A6.19 STOREY, R F, WILCOX, R G and HEPTINSTALL, S, 1998. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Circulation (Baltimore). 98(16), 1616-21
SANDERSON, H M, FOX, S C, ROBBINS, R A, LÖSCHE, W, SPANGENBERG, P and HEPTINSTALL, S, 1998. Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood. Platelets. 9(3-4), 245-50
GLENN, J R and HEPTINSTALL, S, 1998. Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium. Thrombosis and Haemostasis. 80(2), 321-5
LÖSCHE, W, REDLICH, H, KRAUSE, S, HEPTINSTALL, S and SPANGENBERG, P, 1998. Activation of leukocytes in whole blood samples by N-formyl-methionyl-leucyl-phenylalanine (FMLP) enhances platelet aggregability but not platelet P-selectin exposure and adhesion to leukocytes. Platelets. 9(3-4), 219-21
VICKERS, J, LÖSCHE, W, DÖPEL, E, HEPTINSTALL, S, STEIN, G and SPANGENBERG, P, 1998. Measurement of platelet activation and adhesion to leukocytes during haemodialysis. Platelets. 9(3-4), 261-4
MAY, J A, RATAN, H, GLENN, J R, LÖSCHE, W, SPANGENBERG, P and HEPTINSTALL, S, 1998. GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly. Platelets. 9(3-4), 227-32
EDWARDS, C M, HEPTINSTALL, S and LOWE, K C, 1998. Pluronic F-68 inhibits agonist-induced platelet aggregation in human whole blood in vitro. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 26(5-6), 441-7 EVANS, P A, GLENN, J R, HEPTINSTALL, S and MADIRA, W, 1998. Effects of gelatin-based resuscitation fluids on platelet aggregation. British Journal of Anaesthesia. 81(2), 198-202
EDWARDS, C M, HEPTINSTALL, S and LOWE, K C, 1997. Effects of the co-polymer surfactant, Pluronic F-68, on platelet aggregation in human whole blood. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 25(5), 493-9 EDWARDS, C M, LOWE, K C, HEPTINSTALL, S, LUCAS, P, TRABELSI, H and CAMBON, A, 1997. Novel fluoro-surfactants for perfluorochemical emulsification. Effects on aggregation of human platelets in vitro and possible applications as anti-thrombotic agents. Advances in Experimental Medicine and Biology. 428, 489-93
REDLICH, H, VICKERS, J, LÖSCHE, W, HEPTINSTALL, S, KEHREL, B and SPANGENBERG, P, 1997. Formation of platelet-leukocyte conjugates in whole blood. Platelets. 8(6), 419-25
EVANS, P A, MADIRA, W, RIYATT, M S, ERRINGTON, M and HEPTINSTALL, S, 1997. Changes in plasma ionised calcium within 24 hours of trauma in patients infused with the calcium containing colloid Haemaccel during fluid resuscitation. Journal of Accident and Emergency Medicine. 14(2), 73-5
YUSUF, S W, SANDERSON, H, HEPTINSTALL, S, NURDEN, A T, WENHAM, P W and HOPKINSON, B R, 1996. ADP-induced P-selectin expression on platelets as a predictor of successful thrombolysis. Blood Coagulation and Fibrinolysis. 7(2), 266-9 EDWARDS, C M, MAY, J A, HEPTINSTALL, S and LOWE, K C, 1996. Effects of pluronic F-68 (poloxamer 188) on platelet aggregation in human whole blood. Thrombosis Research. 81(4), 511-2 MAY, J. A., HEPTINSTALL, S. and SPANGENBERG, P., 1996. Changes in the composition of the platelet cytoskeleton in response to ADP: effects of MK-852 and ARL 66096 Blood Coagulation and Fibrinolysis. VOL 7(NUMBER SUP//2), 221-224 HORN, E H, HARDY, E, COOPER, J, HEPTINSTALL, S and RUBIN, P C, 1996. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy. Thrombosis and Haemostasis. 75(2), 346-51
LöSCHE, W, DRESSEL, M, KRAUSE, S, REDLICH, H, SPANGENBERG, P and HEPTINSTALL, S, 1996. Contact-induced modulation of neutrophil elastase secretion and phagocytic activity by platelets. Blood Coagulation and Fibrinolysis. 7(2), 210-3
MAY JA, HEPTINSTALL S and SPANGENBERG P, 1996. Changes in the composition of the platelet cytoskeleton in response to adp: effects of mk-852 and arl 66096. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 7(2), 221-4
HEPTINSTALL, S, GLENN, J R, LöSCHE, W and SPANGENBERG, P, 1995. ADP-induced platelet aggregation and actin polymerization. Involvement of GpIIb/IIIa and the effect of Mg2+. Seminars in thrombosis and hemostasis.. 21(2), 137-45 ARMSTRONG, R, MAY, J A, LöSCHE, W and HEPTINSTALL, S, 1995. Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood. Thrombosis and Haemostasis. 73(2), 297-303
HEPTINSTALL, S, MAY, J A, GLENN, J R, SANDERSON, H M, DICKINSON, J P and WILCOX, R G, 1995. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood. Thrombosis and Haemostasis. 74(5), 1310-5
HARDY, E., GLENN, J., HEPTINSTALL, S. and RUBIN, P. C., 1995. Magnesium Modifies the Responses of Platelets to Inhibitory Agents which Act Via cAMP Thrombosis and Haemostasis. VOL 74(NUMBER 4), 1132
HORN, E. H., COOPER, J. A., HARDY, E. and HEPTINSTALL, S., 1995. Longitudinal studies of platelet cyclic AMP during healthy pregnancy and pregnancies at risk of pre-eclampsia Clinical Science. VOL 89(NUMBER 1), 91
HORN EH, COOPER JA, HARDY E, HEPTINSTALL S and RUBIN PC, 1995. Longitudinal studies of platelet cyclic amp during healthy pregnancy and pregnancies at risk of pre-eclampsia. Clinical science (london, england : 1979). 89(1), 91-9
LOUDEN, K A, BROUGHTON PIPKIN, F, HEPTINSTALL, S, FOX, S C, TUOHY, P, O'CALLAGHAN, C, MITCHELL, J R and SYMONDS, E M, 1994. Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. British Journal of Obstetrics and Gynaecology. 101(3), 203-8 ANDREWS, R, MAY, J A, VICKERS, J and HEPTINSTALL, S, 1994. Inhibition of platelet aggregation by transdermal glyceryl trinitrate. British Heart Journal. 72(6), 575-9
HEPTINSTALL S, 1994. Antiplatelet therapy and vascular disease. Platelets. 5(1), 1-2 LONSDALE, R. J., HEPTINSTALL, S., WESTBY, J. C. and BERRIDGE, D. C., 1993. A Study of the Use of the Thromboxane A~2 Antagonist, Sulotroban, in Combination with Streptokinase for Local Thrombolysis in Patients with Recent Peripheral Arterial Occlusions: Clinical Effects, Platelet Function and Fibrinolytic Parameters Thrombosis and Haemostasis. VOL 69(NUMBER 2), 103
LONSDALE RJ, HEPTINSTALL S, WESTBY JC, BERRIDGE DC, WENHAM PW, HOPKINSON BR and MAKIN GS, 1993. A study of the use of the thromboxane a2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters. Thrombosis and haemostasis. 69(2), 103-11, 123
GROENEWEGEN, W A, KNIGHT, D W and HEPTINSTALL, S, 1992. Progress in the medicinal chemistry of the herb feverfew. Progress in medicinal chemistry.. 29, 217-38
MARLES, R J, KAMINSKI, J, ARNASON, J T, PAZOS-SANOU, L, HEPTINSTALL, S, FISCHER, N H, CROMPTON, C W, KINDACK, D G and AWANG, D V, 1992. A bioassay for inhibition of serotonin release from bovine platelets. Journal of natural products.. 55(8), 1044-56 HEPTINSTALL, S, GLENN, J and SPANGENBERG, P, 1992. Changes in G-actin after platelet activation in platelet rich plasma. Thrombosis and Haemostasis. 68(6), 727-30
LOUDEN, K A, BROUGHTON PIPKIN, F, SYMONDS, E M, TUOHY, P, O'CALLAGHAN, C, HEPTINSTALL, S, FOX, S and MITCHELL, J R, 1992. A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension. British Journal of Obstetrics and Gynaecology. 99(5), 371-6 HEPTINSTALL, S, AWANG, D V, DAWSON, B A, KINDACK, D, KNIGHT, D W and MAY, J, 1992. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products. Journal of Pharmacy and Pharmacology. 44(5), 391-5 LOUDEN, K A, BROUGHTON PIPKIN, F, HEPTINSTALL, S, FOX, S C, MITCHELL, J R and SYMONDS, E M, 1991. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. British Journal of Obstetrics and Gynaecology. 98(12), 1239-44 LöSCHE, W, VICKERS, J, MAY, J and HEPTINSTALL, S, 1991. The platelet aggregating activity of 2,3-diphosphoglycerate may be caused by ADP impurity. Thrombosis Research. 61(2), 175-7 SPANGENBERG, P, HEPTINSTALL, S, CRAWFORD, J and TILL, U, 1991. Measurements of the G-/F-actin equilibrium in ADP-stimulated human platelets. Acta histochemica. Supplementband.. 41, 181-6
HORN, E H, COOPER, J, HARDY, E, HEPTINSTALL, S and RUBIN, P C, 1991. A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnant women. Clinical Science. 80(6), 549-58
LOUDEN, K A, BROUGHTON PIPKIN, F, HEPTINSTALL, S, FOX, S C, MITCHELL, J R and SYMONDS, E M, 1990. A longitudinal study of platelet behaviour and thromboxane production in whole blood in normal pregnancy and the puerperium. British Journal of Obstetrics and Gynaecology. 97(12), 1108-14 MAY, J, LOESCHE, W and HEPTINSTALL, S, 1990. Glucose increases spontaneous platelet aggregation in whole blood. Thrombosis Research. 59(3), 489-95 KILBY, M D, BROUGHTON PIPKIN, F, COCKBILL, S, HEPTINSTALL, S and SYMONDS, E M, 1990. A cross-sectional study of basal platelet intracellular free calcium concentration in normotensive and hypertensive primigravid pregnancies. Clinical Science. 78(1), 75-80
KRAUSE, S, ARESE, P, HEPTINSTALL, S and LöSCHE, W, 1990. Influence of substances affecting cell sulfhydryl/disulfide status on adherence of human monocytes. Arzneimittel-Forschung.. 40(6), 689-92
PATTRICK, M, HEPTINSTALL, S and DOHERTY, M, 1989. Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Annals of the Rheumatic Diseases. 48(7), 547-9 GLUSA, E, BEVAN, J and HEPTINSTALL, S, 1989. Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation. Thrombosis Research. 55(2), 239-245 TILL, U, BERGMANN, I, BREDDIN, K, HEPTINSTALL, S, LöSCHE, W, MAZUROV, A and PESCARMONA, G, 1989. Sulfhydryl/disulfide-status of blood platelets--a target for pharmacological intervention? Progress in clinical and biological research.. 301, 341-5
LöSCHE, W, MICHEL, E, LULL, K, KREUTZFELD, B, HEPTINSTALL, S and TILL, U, 1989. [The effect of high glucose concentrations on the osmotic and mechanical resistance of human erythrocytes] Zeitschrift für medizinische Laboratoriumsdiagnostik.. 30(2), 124-7
KRAUSE, S, MICHEL, E, BRACHMANN, P, LöSCHE, W, HEPTINSTALL, S and TILL, U, 1989. [Cellular chemiluminescence of activated phagocytes of whole blood] Folia haematologica (Leipzig, Germany : 1928). 116(6), 955-65
HEPTINSTALL, S, COCKBILL, S R, BURGESS-WILSON, M E and JONES, E W, 1988. Studies on platelets before and after stroke in a patient with essential thrombocythaemia. British medical journal (Clinical research ed.). 296(6632), 1298-9
COCKBILL, S R, BURMESTER, H B and HEPTINSTALL, S, 1988. Pseudo grey platelet syndrome--grey platelets due to degranulation in blood collected into EDTA. European Journal of Haematology. 41(4), 326-33
LOESCHE, W, MAZUROV, A V, VOYNO-YASENETSKAYA, T A, GROENEWEGEN, W A, HEPTINSTALL, S and REPIN, V S, 1988. Feverfew--an antithrombotic drug? Folia haematologica (Leipzig, Germany : 1928). 115(1-2), 181-4
LOESCHE, W, GROENEWEGEN, W A, KRAUSE, S, SPANGENBERG, P and HEPTINSTALL, S, 1988. Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets. Biomedica biochimica acta.. 47(10-11), S241-3
VOYNO-YASENETSKAYA, T A, LOESCHE, W, GROENEWEGEN, W A, HEPTINSTALL, S, REPIN, V S and TILL, U, 1988. Effects of an extract of feverfew on endothelial cell integrity and on cAMP in rabbit perfused aorta. Journal of Pharmacy and Pharmacology. 40(7), 501-2 HEPTINSTALL, S, GROENEWEGEN, W A, SPANGENBERG, P and LöSCHE, W, 1988. Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia haematologica (Leipzig, Germany : 1928). 115(4), 447-9
LöSCHE, W, BEVAN, J, MICHEL, E, HEPTINSTALL, S and TILL, U, 1988. [Effect of high glucose concentrations on spontaneous aggregation of human blood platelets] Zeitschrift für medizinische Laboratoriumsdiagnostik.. 29(1), 55-8
HEPTINSTALL, S and BEVAN, J, 1988. How can we inhibit 5-HT-induced platelet aggregation and why should we bother? Folia haematologica (Leipzig, Germany : 1928). 115(4), 475-8
LöSCHE, W, MICHEL, E, HEPTINSTALL, S, KRAUSE, S, GROENEWEGEN, W A, PESCARMONA, G P and THIELMANN, K, 1988. Inhibition of the behaviour of human polynuclear leukocytes by an extract of Chrysanthemum parthenium. Planta medica.. 54(5), 381-4 HEPTINSTALL, S, 1988. Feverfew--an ancient remedy for modern times? Journal of The Royal Society of Medicine. 81(7), 373-4
BURGESS-WILSON, M E, COCKBILL, S R, JOHNSTON, G I and HEPTINSTALL, S, 1987. Platelet aggregation in whole blood from patients with Glanzmann's thrombasthenia. Blood. 69(1), 38-42
HEPTINSTALL, S, GROENEWEGEN, W A, SPANGENBERG, P and LOESCHE, W, 1987. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. Journal of Pharmacy and Pharmacology. 39(6), 459-65
HEPTINSTALL, S, 1987. Haematology, ethnography, and thrombosis. British medical journal (Clinical research ed.). 294(6563), 3-4
BURGESS-WILSON, M.E., COCKBILL, S.R., JOHNSTON, G.I. and HEPTINSTALL, S., 1987. Platelet aggregation in whole blood from patients with Glanzmann's thrombasthenia. Blood. 69, 38-42 LöSCHE, W, MAZUROV, A V, HEPTINSTALL, S, GROENEWEGEN, W A, REPIN, V S and TILL, U, 1987. An extract of feverfew inhibits interactions of human platelets with collagen substrates. Thrombosis Research. 48(5), 511-8 MAURICE, P D, ALLEN, B R, HEPTINSTALL, S and BATHER, P C, 1986. Arachidonic acid metabolism by peripheral blood cells in psoriasis. British Journal of Dermatology. 114(5), 553-66 BURGESS-WILSON, M E, MORRISON, R and HEPTINSTALL, S, 1986. Spontaneous platelet aggregation in heparinised blood during pregnancy. Thrombosis Research. 41(3), 385-93 SILLS, T and HEPTINSTALL, S, 1986. Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour. Thrombosis and Haemostasis. 55(3), 305-8
PEACOCK, I, HAWKINS, M and HEPTINSTALL, S, 1986. Platelet behaviour in non-insulin-dependent diabetes--influence of vascular complications, treatment and metabolic control. Thrombosis and Haemostasis. 55(3), 361-5
HEPTINSTALL, S, FOX, S, CRAWFORD, J and HAWKINS, M, 1986. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin. Thrombosis Research. 42(2), 215-23 GROENEWEGEN, W A and HEPTINSTALL, S, 1986. Amounts of feverfew in commercial preparations of the herb. Lancet. 1(8471), 44-5 MORRISON, R, CRAWFORD, J, MACPHERSON, M and HEPTINSTALL, S, 1985. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thrombosis and Haemostasis. 54(3), 607-11
COWLEY, A J, JONES, E W, CARTER, A J, HANLEY, S P and HEPTINSTALL, S, 1985. The effects of dazoxiben, an inhibitor of thromboxane synthetase, on cold-induced forearm vasoconstriction and platelet behaviour in different individuals. British Journal of Clinical Pharmacology. 19(1), 1-8
ANDREWS, N P, BROUGHTON PIPKIN, F and HEPTINSTALL, S, 1985. Blood platelet behaviour in mothers and neonates. Thrombosis and Haemostasis. 53(3), 428-32
CARTER, A J and HEPTINSTALL, S, 1985. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate. Thrombosis and Haemostasis. 54(3), 612-6
JOHNSTON, G I, HEPTINSTALL, S and LöSCHE, W, 1985. Effects of diamide and iodoacetamide on the expression of the glycoprotein IIb/IIIa complex on blood platelets. Biochemical and Biophysical Research Communications. 127(3), 822-7 COWLEY, A J, HEPTINSTALL, S and MITCHELL, J R, 1985. Similarity between platelet and blood-vessel reactivity. Lancet. 2(8447), 154-5 LöSCHE, W, BURGESS-WILSON, M, MICHEL, E, HEPTINSTALL, S and TILL, U, 1985. Diamide induces reversible aggregation of human blood platelets. Thrombosis Research. 40(6), 869-74 COWLEY, A J, HEPTINSTALL, S and HAMPTON, J R, 1985. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man. Thrombosis and Haemostasis. 53(1), 90-4
COWLEY, A J, STAINER, K, COCKBILL, S and HEPTINSTALL, S, 1984. Correlation between platelet behaviour and cold-induced vasoconstriction in man, and the effects of epoprostenol infusion. Clinical Science. 67(5), 511-4
HEPTINSTALL, S, 1984. Properties of blood platelets that may be relevant to atherogenesis. VASA. Zeitschrift für Gefässkrankheiten. Journal for vascular diseases.. 13(4), 343-9
BURGESS-WILSON, M E, GREEN, S, HEPTINSTALL, S and MITCHELL, J R, 1984. Spontaneous platelet aggregation in whole blood: dependence on age and haematocrit. Lancet. 2(8413), 1213
HEPTINSTALL, S and FOX, S C, 1983. Human blood platelet behaviour after inhibition of thromboxane synthetase. British Journal of Clinical Pharmacology. 15 Suppl 1, 31S-37S
JONES, E W, COCKBILL, S R, COWLEY, A J, HANLEY, S P and HEPTINSTALL, S, 1983. Effects of dazoxiben and low-dose aspirin on platelet behaviour in man. British Journal of Clinical Pharmacology. 15 Suppl 1, 39S-44S
MULLEY, G P, HEPTINSTALL, S, TAYLOR, P M and MITCHELL, J R, 1983. ADP-induced platelet release reaction in acute stroke. Thrombosis and Haemostasis. 50(2), 524-6
BILLETT, E, HANLEY, S, HEPTINSTALL, S and MAYER, R J, 1983. Monoamine oxidase activity in diabetes. Diabetes. 32(2), 130-3 FOX, S C, BURGESS-WILSON, M, HEPTINSTALL, S and MITCHELL, J R, 1982. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thrombosis and Haemostasis. 48(3), 327-9
HANLEY, S P, BEVAN, J, COCKBILL, S R and HEPTINSTALL, S, 1982. A regimen for low-dose aspirin? British medical journal (Clinical research ed.). 285(6351), 1299-302
BURNHAM, W R, HEPTINSTALL, S, COCKBILL, S R and HARRISON, S, 1982. Blood platelet behaviour during infusion of an Intralipid-based intravenous feeding mixture. Postgraduate Medical Journal. 58(677), 152-5 HEPTINSTALL, S, BEVAN, J, COCKBILL, S R, HANLEY, S P and PARRY, M J, 1980. Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour. Thrombosis Research. 20(2), 219-30 HEPTINSTALL, S, MULLEY, G P, TAYLOR, P M and MITCHELL, J R, 1980. Platelet-release reaction in myocardial infarction. British medical journal.. 280(6207), 80-1
TAYLOR, P M and HEPTINSTALL, S, 1980. The abilities of human blood platelets to bind extracellular calcium and to be aggregated by adenosine diphosphate are related. British Journal of Haematology. 46(1), 115-22
HEPTINSTALL, S, 1980. Platelet behaviour and vascular disease. Artery.. 8(5), 448-56
HEPTINSTALL, S and TAYLOR, P M, 1979. The effects of citrate and extracellular calcium ions on the platelet release reaction induced by adenosine diphosphate and collagen. Thrombosis and Haemostasis. 42(2), 778-93
COCKBILL, S R and HEPTINSTALL, S, 1978. A method for estimating prostaglandin synthetase activity in blood platelets and the extent of its pharmacological inhibition [proceedings] Journal of Physiology. 276, 15P-16P
HEPTINSTALL, S and TAYLOR, P M, 1978. The influence of anticoagulants and extracellular divalent cations on blood platelet behaviour [proceedings] Journal of Physiology. 276, 25P-26P
WHITE, A M and HEPTINSTALL, S, 1978. Contribution of platelets to thrombus formation. British Medical Bulletin. 34(2), 123-8
TAYLOR, P M and HEPTINSTALL, S, 1978. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction. Thrombosis and Haemostasis. 39(2), 550-1
ADAMS, J, HEPTINSTALL, S and MITCHELL, J R, 1975. A six-channel automated platelet aggregometer. Thrombosis et diathesis haemorrhagica.. 34(3), 821-4
ARCHIBALD, A R, BADDILEY, J, HECKELS, J E and HEPTINSTALL, S, 1971. Further studies on the glycerol teichoic acid of walls of Staphylococcus lactis I3. Location of the phosphodiester groups and their susceptibility to hydrolysis with alkali. Biochemical Journal. 125(1), 353-9
ARCHIBALD, A R and HEPTINSTALL, S, 1971. The teichoic acids of Micrococcus sp. 24. Biochemical Journal. 125(1), 361-3
HEPTINSTALL, S, ARCHIBALD, A R and BADDILEY, J, 1970. Teichoic acids and membrane function in bacteria. Nature. 225(5232), 519-21 ARCHIBALD, A R, BADDILEY, J and HEPTINSTALL, S, 1969. The distribution of the glucosyl substituents along the chain of the teichoic acid in walls of Lactobacillus buchneri N.C.I.B. 8007. Biochemical Journal. 111(2), 245-6
ARCHIBALD, A R, BADDILEY, J, BUTTON, D, HEPTINSTALL, S and STAFFORD, G H, 1968. Ocuurrence of polymers containing N-acetylglucosamine-1-phosphate in bacterial walls. Nature. 219(156), 855-6